Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit
Abstract Influenza virus uses a unique mechanism to initiate viral transcription named cap-snatching. The PB2 subunit of the viral heterotrimeric RNA polymerase binds the cap structure of cellular pre-mRNA to promote its cleavage by the PA subunit. The resulting 11–13 capped oligomer is used by the...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0e992cb2a2914995a1aae7e6664172d2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0e992cb2a2914995a1aae7e6664172d2 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0e992cb2a2914995a1aae7e6664172d22021-12-02T15:04:59ZStructural basis for therapeutic inhibition of influenza A polymerase PB2 subunit10.1038/s41598-017-09538-x2045-2322https://doaj.org/article/0e992cb2a2914995a1aae7e6664172d22017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09538-xhttps://doaj.org/toc/2045-2322Abstract Influenza virus uses a unique mechanism to initiate viral transcription named cap-snatching. The PB2 subunit of the viral heterotrimeric RNA polymerase binds the cap structure of cellular pre-mRNA to promote its cleavage by the PA subunit. The resulting 11–13 capped oligomer is used by the PB1 polymerase subunit to initiate transcription of viral proteins. VX-787 is an inhibitor of the influenza A virus pre-mRNA cap-binding protein PB2. This clinical stage compound was shown to bind the minimal cap-binding domain of PB2 to inhibit the cap-snatching machinery. However, the binding of this molecule in the context of an extended form of the PB2 subunit has remained elusive. Here we generated a collection of PB2 truncations to identify a PB2 protein representative of its structure in the viral heterotrimeric protein. We present the crystal structure of VX-787 bound to a PB2 construct that recapitulates VX-787's biological antiviral activity in vitro. This co-structure reveals more extensive interactions than previously identified and provides insight into the observed resistance profile, affinity, binding kinetics, and conformational rearrangements induced by VX-787.Xiaolei MaLili XieCharles WartchowRobert WarneYongjin XuAlexey RivkinDavid TullySteven ShiaKyoko UeharaDianna M. BaldwinGladys MuiruWeidong ZhongIsabel ZarorDirksen E. BussiereVincent H. J. LeonardNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Xiaolei Ma Lili Xie Charles Wartchow Robert Warne Yongjin Xu Alexey Rivkin David Tully Steven Shia Kyoko Uehara Dianna M. Baldwin Gladys Muiru Weidong Zhong Isabel Zaror Dirksen E. Bussiere Vincent H. J. Leonard Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit |
| description |
Abstract Influenza virus uses a unique mechanism to initiate viral transcription named cap-snatching. The PB2 subunit of the viral heterotrimeric RNA polymerase binds the cap structure of cellular pre-mRNA to promote its cleavage by the PA subunit. The resulting 11–13 capped oligomer is used by the PB1 polymerase subunit to initiate transcription of viral proteins. VX-787 is an inhibitor of the influenza A virus pre-mRNA cap-binding protein PB2. This clinical stage compound was shown to bind the minimal cap-binding domain of PB2 to inhibit the cap-snatching machinery. However, the binding of this molecule in the context of an extended form of the PB2 subunit has remained elusive. Here we generated a collection of PB2 truncations to identify a PB2 protein representative of its structure in the viral heterotrimeric protein. We present the crystal structure of VX-787 bound to a PB2 construct that recapitulates VX-787's biological antiviral activity in vitro. This co-structure reveals more extensive interactions than previously identified and provides insight into the observed resistance profile, affinity, binding kinetics, and conformational rearrangements induced by VX-787. |
| format |
article |
| author |
Xiaolei Ma Lili Xie Charles Wartchow Robert Warne Yongjin Xu Alexey Rivkin David Tully Steven Shia Kyoko Uehara Dianna M. Baldwin Gladys Muiru Weidong Zhong Isabel Zaror Dirksen E. Bussiere Vincent H. J. Leonard |
| author_facet |
Xiaolei Ma Lili Xie Charles Wartchow Robert Warne Yongjin Xu Alexey Rivkin David Tully Steven Shia Kyoko Uehara Dianna M. Baldwin Gladys Muiru Weidong Zhong Isabel Zaror Dirksen E. Bussiere Vincent H. J. Leonard |
| author_sort |
Xiaolei Ma |
| title |
Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit |
| title_short |
Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit |
| title_full |
Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit |
| title_fullStr |
Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit |
| title_full_unstemmed |
Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit |
| title_sort |
structural basis for therapeutic inhibition of influenza a polymerase pb2 subunit |
| publisher |
Nature Portfolio |
| publishDate |
2017 |
| url |
https://doaj.org/article/0e992cb2a2914995a1aae7e6664172d2 |
| work_keys_str_mv |
AT xiaoleima structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT lilixie structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT charleswartchow structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT robertwarne structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT yongjinxu structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT alexeyrivkin structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT davidtully structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT stevenshia structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT kyokouehara structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT diannambaldwin structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT gladysmuiru structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT weidongzhong structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT isabelzaror structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT dirksenebussiere structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit AT vincenthjleonard structuralbasisfortherapeuticinhibitionofinfluenzaapolymerasepb2subunit |
| _version_ |
1718388936839004160 |